MDXH MDxHealth SA
Company Analysis
Latest News
π’ MDxHealth is trading 6.5% up in after-hours trading after a 12.20% August 18 decline
MDxHealth is trading at $0.80 (+6.50%) in after-hours trading after rebounding from an unusually volatile recent stretch. - MDxHealth declined 12.20% in...
π΄ MDxHealth is trading 11% down today amid profit-taking after sharp rally
MDxHealth is trading at $0.77, down 10.57%, amid profit-taking after a sharp rally in prior sessions. - Shares gained 74.89% on August 14 and 5.89% on August...
π΄ MDxHealth is trading 5% down today amid profit-taking after recent rally
MDxHealth is trading 5% down at $0.81, primarily amid broader risk-off sentiment and profit-taking after its recent rally. - No new company-specific...
π΄ MDxHealth is trading 5.2% down in pre-market
MDxHealth is trading at 5.2% down now at $0.81 after declining in pre-market trading. - The alert reflects the stockβs current pre-market move. - No specific...
π’ MDxHealth is trading 13.28% up today after Q2 revenue rose 16% to $27.2 million
MDxHealth is trading 13.28% up at $0.92 after reporting Q2 revenue of $27.2 million, up 16% year over year. β’ Management reaffirmed 2026 revenue guidance of...
π’ MDxHealth is trading 7.75% up today after Q2 revenue rose 16%
MDxHealth is trading $0.87 (+7.75%) after reporting Q2 revenue of $27.2 million, up 16% year over year. - Extending the sharp August 14 rally while...
MDxHealth Doubled Its Share Count to Raise $20 Million β Can a Revenue Rebound Outrun the Dilution and a Looming Nasdaq Deadline?
Shares of MDxHealth plunged 16.8% to $0.67 on August 17, erasing much of a 74.9% spike just three days earlier, as investors weighed a massive share sale...
π΄ MDxHealth is trading 16.83% down in pre-market after dilution concerns from a $20 million placement
MDxHealth is trading at $0.67 (-16.83%) in pre-market amid dilution concerns from its registered direct placement. - The $20 million registered direct...
MDxHealth Beats Q2 Revenue Estimates, Targets 2026 Profitability
MDxHealth reported second-quarter 2026 revenue of $27.2 million. This represents a 16% year-over-year increase and exceeded analyst expectations. Growth was...